NASDAQ: AVBP · Health Care / Biotechnology: Pharmaceutical Preparations

ArriVent BioPharma Inc.

How ArriVent BioPharma Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$1.0B

Price

$21.00

P/E

-6.2

EPS (TTM)

$-3.39

1-year return

27.1%

Dividend yield

0.0%

52-week range

$15.09–$27.05

Compared with

• Biotechnology: Pharmaceutical Preparations industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources